These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9711593)
1. Cationic lipid formulations for intracellular gene delivery of cystic fibrosis transmembrane conductance regulator to airway epithelia. Cheng SH; Marshall J; Scheule RK; Smith AE Methods Enzymol; 1998; 292():697-717. PubMed ID: 9711593 [No Abstract] [Full Text] [Related]
2. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152 [TBL] [Abstract][Full Text] [Related]
3. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. McLachlan G; Davidson DJ; Stevenson BJ; Dickinson P; Davidson-Smith H; Dorin JR; Porteous DJ Gene Ther; 1995 Nov; 2(9):614-22. PubMed ID: 8548550 [TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors for gene therapy of cystic fibrosis. Flotte TR; Carter BJ Methods Enzymol; 1998; 292():717-32. PubMed ID: 9711594 [No Abstract] [Full Text] [Related]
5. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes. Fortunati E; Bout A; Zanta MA; Valerio D; Scarpa M Biochim Biophys Acta; 1996 Apr; 1306(1):55-62. PubMed ID: 8611625 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy: the case for cystic fibrosis. Alton EW; Geddes D J R Soc Med; 1997; 90 Suppl 31(Suppl 31):43-6. PubMed ID: 9204011 [No Abstract] [Full Text] [Related]
16. Gene therapy progress and prospects: cystic fibrosis. Griesenbach U; Ferrari S; Geddes DM; Alton EW Gene Ther; 2002 Oct; 9(20):1344-50. PubMed ID: 12364999 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for cystic fibrosis by means of aerosol. Rochat T; Morris MA J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873 [TBL] [Abstract][Full Text] [Related]
18. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Lu D; Benjamin R; Kim M; Conry RM; Curiel DT Cancer Gene Ther; 1994 Dec; 1(4):245-52. PubMed ID: 7627814 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway. Sorscher EJ; Logan JJ; Frizzell RA; Lyrene RK; Bebok Z; Dong JY; Duvall MD; Felgner PL; Matalon S; Walker L Hum Gene Ther; 1994 Oct; 5(10):1259-77. PubMed ID: 7531503 [No Abstract] [Full Text] [Related]
20. A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. Zabner J; Chillon M; Grunst T; Moninger TO; Davidson BL; Gregory R; Armentano D J Virol; 1999 Oct; 73(10):8689-95. PubMed ID: 10482622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]